We thank Dr Badruddoja for his keen comment and interest in our article. Tumor size was included in many staging systems as an independent predictor of survival. Multiple data sets demonstrate an excellent prognosis for node-negative, but 1-cm or less sized cancers.1 In treating our patients, we sometimes see “borderline” tumor sizes close to 1 cm or 2 cm but not over. In these cases, clinicians have difficulty in deciding whether adjuvant chemotherapy is needed and what the true T stage of the patient is for prognosis. Accordingly, this study aims to figure out whether preoperative core-needle biopsy (CNB) may alter the T stage and affect the decision of adjuvant chemotherapy.
Yang J. Size of Breast Cancer Tumor After Core-Needle Biopsy and Fine-Needle Aspiration Does Not Affect Patient Treatment Plan—Reply. Arch Surg. 2005;140(10):1009. doi:10.1001/archsurg.140.10.1009-a
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: